Seven-year-old boy has three-inch nail removed from his BRAIN by incredible surgeons after he fell on it in horrific India playtime accident
A seven-year-old boy had a more than three-inch nail removed from his brain by heroic surgeons in India after he accidentally fell on it while playing.
In a rare freak accident on May 15, the young boy, currently unnamed and based in the Nawazpur district of Balrampur, had been innocently playing when he fell on the exposed nail which then entered his neck.
His panicked parents, who were entirely unaware of the unbelievable length of the nail, immediately rushed him to a nearby hospital, before he was later admitted to a trauma centre in the city of Lucknow.
Following MRI and CT scans to identify the size and exact positioning of the metal piece, specialist trauma surgeons were then horrified to discover that the tip of the whopping 8cm nail was poking at the young boy's brain.
The following day, the child underwent a grueling 10-hour-long 'highly complicated surgery' to remove the significant perforation, with doctors working tirelessly to ensure that his brain was not harmed in the process.
Miraculously, using advanced microsurgical techniques and neuro-navigation technology, incredible surgeons at King George's Medical University were able to extract the nail without damaging any critical blood vessels.
A fascinating post-op image has shown how the iron piece that had punctured his skin measured more than three inches.
Revealing the extraordinary nature of the incident, Dr Sandip Tiwari, who heads the trauma surgery department where the young boy was treated, said: 'The investigation revealed that the nail had missed a major blood vessel by a fraction, which was nothing short of miraculous.
'After consulting experts, we decided to proceed with a highly complicated surgery.'
Following the procedure, the seven-year-old was placed in intensive care to recover, receiving observation by medical personnel.
And, thanks to the complex work of the heroic doctors, the young boy has now made a full recovery, with the incredibly complex surgery now expected to be described in an international medical journal.
Pictured: the iron piece that had punctured the young boy's skin measured 8cm, equating to more than three inches. Dr Sandip Tiwari, who heads the trauma surgery department where the young boy was treated, described his recovery as 'nothing short of miraculous'
The unusual case comes more than a year after Celia Trello, of Peru, was reported to have accidentally swallowed a 5cm nail that was stuck in a port rind.
The 69-year-old, who was eating the snack in February 2024, eventually took herself to an emergency room after reporting feeling unwell and eventually vomiting blood.
The nail, which was piercing one of her cartoid arteries, was successfully removed by a team of surgeons during a three-hour procedure. While the operation left a huge scar on Ms Trello's neck, she was able to leave the hospital in a stable condition.
According to the Peruvian State website, the 68-year-old woman's case was the first to be reported and successfully treated in Peru.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
3 hours ago
- Daily Mail
I've fixed thousands of brains and seen proof we have a soul... just look at conjoined twins, even trees
A neurosurgeon who has performed more than 7,000 surgeries believes he has proof that people possess souls, pointing to everything from dying patients and conjoined twins to trees. When Michael Egnor, 69, began studying to become a neurosurgeon decades ago, he most certainly didn't believe in the concept.
BBC News
4 hours ago
- BBC News
Superbugs thrive as access to antibiotics fails in India
It's a grim paradox, doctors the one hand, antibiotics are being overused until they no longer work, driving resistance and fuelling the rise of deadly superbugs. On the other hand, people are dying because they can't access these life-saving drugs.A new study by the non-profit Global Antibiotic Research and Development Partnership (GARDP) looked at access to antibiotics for nearly 1.5 million cases of carbapenem-resistant Gram-negative (CRGN) infections across eight major low- and middle-income countries, including India, Brazil and South Africa. CRGN bacteria are superbugs resistant to last-line antibiotics - yet only 6.9% of patients received appropriate treatment in the countries bore the lion's share of CRGN infections and treatment efforts, procuring 80% of the full courses of studied antibiotics but managing to treat only 7.8% of its estimated cases, the study in The Lancet Infectious Diseases journal reports. (A full drug course of antibiotics refers to the complete set of doses that a patient needs to take over a specific period to fully treat an infection.) Common in water, food, the environment and the human gut, Gram-negative bacteria cause infections such as urinary tract infections (UTIs), pneumonia and food poisoning. They can pose a serious threat to newborns and the elderly alike. Especially vulnerable are hospital patients with weakened immunity, often spreading rapidly in ICUs and proving difficult - and sometimes impossible - to treat. Treating carbapenem-resistant Gram-negative bacterial infections is doubly difficult because those bacteria are resistant to some of the most powerful antibiotics."These infections are a daily reality across all age groups," says Dr Abdul Gaffar, infectious disease consultant at Apollo Hospital in India's Chennai city. "We often see patients for whom no antibiotic works - and they die."The irony is cruel. While the world tries to curb antibiotic overuse, a parallel tragedy plays out quietly in poorer nations: people dying from treatable infections because the right drugs are out of reach. "For years, the dominant narrative has been that antibiotics are being overused, but the stark reality is that many people with highly drug-resistant infections in low- and middle-income countries are not getting access to the antibiotics they need," says Dr Jennifer Cohn, GARDP's Global Access Director and senior author of the 'blockbuster' drugs to take on deadly superbugsIndia facing a pandemic of antibiotics-resistant superbugsThe study examined eight intravenous drugs active against carbapenem-resistant bacteria - ranging from older antibiotics including Colistin to newer ones such as Ceftazidime-avibactam. Of the few available drugs, Tigecycline was the most widely used. Researchers blame the treatment gap on weak health systems and limited access to effective antibiotics. For example, only 103,647 full treatment courses were procured of Tigecycline across eight countries - far short of the 1.5 million patients who needed them, the study found. This highlighted a major shortfall in the global response to drug-resistant infections. What prevents patients with drug-resistant infections in India from getting the right antibiotics? Physicians point to multiple barriers - reaching the right health facility, getting accurate diagnostic tests, and accessing effective drugs. Cost remains a major hurdle, with many of these antibiotics priced far beyond the reach of poorer patients. "Those who can afford these antibiotics often overuse them; those who can't, don't get them at all," says Dr Gaffar. "We need a system that ensures access for the poor and prevents misuse by the well-to-do."To improve access, these drugs must be made more affordable. To prevent misuse, stronger regulation is key. "Ideally, every antibiotic prescription in hospitals should require a second sign-off - by an infection specialist or microbiologist," says Dr Gaffar. "Some hospitals do this, but most don't. With the right oversight, regulators can ensure this becomes standard practice."To fix the access problem and curb misuse, both smarter policies and stronger safeguards are essential, say researchers. But access alone won't solve the crisis - the pipeline of new antibiotics is drying up. The decline in antibiotic R&D - and the limited availability of existing drugs - is a global bears one of the world's heaviest burdens of antimicrobial resistance (AMR), but it may also hold the key to combating it - both at home and globally, researchers say."India is also one of the largest markets for new antibiotics and can successfully advocate for the development and access of new antibiotics," says Dr Cohn. With a strong pharmaceutical base, the country is emerging as a hub for AMR innovation, from promising new antibiotics to advanced Cohn says India can strengthen its antibiotic response by generating local data to better estimate needs and pinpoint gaps in the care pathway. This would allow for more targeted interventions to improve access to the right drugs. Innovative models are already emerging - Kerala state, for instance, is using a "hub-and-spoke approach" to support lower-level facilities in managing serious infections. Coordinated or pooled procurement across hospitals or states could also reduce the cost of newer antibiotics, as seen with cancer drug programs, researchers access to the right antibiotics, modern medicine begins to unravel - doctors risk losing the ability to safely perform surgery, treat complications in cancer patients, or manage everyday infections. "As an infectious disease doctor, I see appropriate use as one part - but only one part - of access," says Dr Gaffar. "When we get new antibiotics, it's important to save them on one hand - and save them for right patients." Clearly, the challenge is not just to use antibiotics wisely, but to ensure they reach those who need them most.
BBC News
4 hours ago
- BBC News
Punjab Kings set up IPL final against RCB
Indian Premier League, Qualifier 2, AhmedabadMumbai Indians 203-6 (20 overs): Suryakumar 44 (26), Varma 44 (29); Azmatullah 2-43Punjab Kings 207-5 (19 overs): Shreyas 87* (41), Wadhera 48 (29); Ashwani 2-55Punjab Kings won by five wicketsScorecard Punjab Kings captain Shreyas Iyer hit a sparkling unbeaten 87 to lead his side to their first Indian Premier League final in 11 years with victory over Mumbai 204 to win, Shreyas clattered eight sixes in his 41-ball knock, smacking Ashwani Kumar into the stands to seal a five-wicket win with an over to the match started over two hours late because of rain in Ahmedabad, Mumbai posted 203-6 in their 20 overs, with Tilak Varma and Suryakumar Yadav both scoring 44 and Jonny Bairstow making 38 off 24 will meet Royal Challengers Bengaluru in Tuesday's final, also taking place at the Narendra Modi Stadium.A new IPL champion will be crowned, with both sides having never won the tournament. "I love such big occasions," said player of the match Shreyas."I always say to myself and to my colleagues in the team that the bigger the occasion, the calmer you are, you get the big results." Punjab won the toss and elected to bowl before the rain arrived, although no overs were play eventually started, Australia all-rounder Marcus Stoinis removed India opener Rohit Sharma for just eight, before Varma and Bairstow combined for 51 strong partnership worth 72 between Varma and Suryakumar put Mumbai in a decent position before both fell in the space of three Naman Dhir's 37 off 18 balls boosted the five-time champions to a challenging reply, Australia wicketkeeper Josh Inglis sparked Punjab with 38 off 21, including 20 off one over from India fast bowler Jasprit Mumbai hit back as captain Hardik Pandya removed Inglis and were marginal favourites when Nehal Wadhera fell for 48, with Kings needing 48 off 26 Shreyas kept his side in contention and, requiring 23 runs off the last two overs, he flicked the switch to smash four sixes in the 19th over in a clinical final is a repeat of the first qualifier match, in which RCB thrashed Kings by eight sides scored 19 points in the group stage, with Kings narrowly topping the table on net-run were beaten by Kolkata Knight Riders in their only previous final appearance in 2014, while RCB have lost the showpiece in 2009, 2011 and 2016.
